natgillin/translations-raw huggingface dataset:
Each ml of ABILIFY oral solution contains 200 mg of fructose and 400 mg of sucrose.
Jedan ml ABILIFY oralne otopine sadrži 200 mg fruktoze i 400 mg saharoze.
Each mL of concentrate contains 0.1 mmol (or 2.5 mg) sodium.
Jedan ml koncentrata sadrži 0,1 mmol (ili 2,5 mg) natrija.
Each ml of concentrate contains 1 mg elosulfase alfa.
Svaki ml koncentrata sadrži 1 mg elosulfaze alfa.
Each ml of concentrate contains 1 mg topotecan (as hydrochloride).
Jedan ml koncentrata sadržava 1 mg topotekana (u obliku topotekanklorida).
Each ml of concentrate contains 2 mg sebelipase alfa*.
Jedan ml koncentrata sadrži 2 mg sebelipaze alfa (sebelipase alfa)*.
Each ml of concentrate contains 20 mg docetaxel (anhydrous).
Jedan ml koncentrata sadržava 20 mg docetaksela (u obliku bezvodnog docetaksela).
Each ml of concentrate contains 20 mg docetaxel (as trihydrate).
l ml koncentrata sadržava 20 mg docetaksela (u obliku docetaksel trihidrata).
Each ml of concentrate contains 20 mg docetaxel anhydrous.
Jedan ml koncentrata sadržava 20 mg docetaksela bezvodnog.
Each ml of concentrate contains 20 mg docetaxel anhydrous.
Jedan ml koncentrata sadržava 20 mg docetaksela, bezvodnog.
Each ml of concentrate contains 20 mg docetaxel as trihydrate.
Jedan ml koncentrata sadržava 20 mg docetaksela u obliku docetaksel trihidrata.
Each ml of concentrate contains 20 mg docetaxel.
Jedan ml koncentrata sadržava 20 mg docetaksela.
Each ml of concentrate contains 20 mg docetaxel.
Jedan ml koncentrata sadrži 20 mg docetaksela.
Each ml of concentrate contains 20 mg of vernakalant hydrochloride which is equivalent to 18.1 mg of vernakalant.
Jedan ml koncentrata sadrži 20 mg vernakalantklorida, što odgovara 18,1 mg vernakalanta.
Each mL of concentrate contains 20 mg panitumumab.
Jedan ml koncentrata sadrži 20 mg panitumumaba.
Each ml of concentrate contains 25 mg of bevacizumab, corresponding to 1.4 to 16.5 mg/ml when diluted as recommended.
Jedan ml koncentrata sadrži 25 mg bevacizumaba, što odgovara 1,4 do 16,5 mg/ml kada se razrijedi sukladno preporuci.
Each ml of concentrate contains 27.73 mg docetaxel.
Jedan ml koncentrata sadržava 27,73 mg docetaksela.
Each ml of concentrate contains 27.73 mg docetaxel.
Jedan ml koncentrata za otopinu sadrži 27 73 mg docetaksela.
Each ml of concentrate contains 27.73 mg docetaxel.
Jedan ml koncentrata za otopinu sadrži 27,73 mg docetaksela.
Each ml of concentrate contains 5 mg ipilimumab.
Jedan ml koncentrata sadrži 5 mg ipilimumaba.
Each ml of concentrate contains 5 mg of ipilimumab.
Jedan ml koncentrata sadrži 5mg ipilimumaba.
Each ml of concentrate contains dexmedetomidine hydrochloride equivalent to 100 micrograms dexmedetomidine.
Jedan ml koncentrata sadrži deksmedetomidinklorid u količini koja odgovara 100 mikrograma deksmedetomidina.
Each ml of concentrate for solution for infusion contains 20 mg docetaxel.
Jedan ml koncentrata za infuzijsku otopinu sadržava 20 mg docetaksela.
Each ml of concentrate for solution for infusion contains 20 mg of docetaxel (anhydrous).
Jedna ml koncentrata za otopinu za infuziju sadržava 20 mg docetaksela (u obliku bezvodnog docetaksela).
Each ml of concentrate for solution for infusion contains 395 mg of ethanol anhydrous.
Jedna ml koncentrata za infuziju sadržava 395 mg etanola, bezvodnog.
Each ml of concentrate for solution for infusion contains 395 mg of ethanol anhydrous.
Jedna ml koncentrata za infuziju sadržava 395 mg) etanola, bezvodnog.
Each ml of docetaxel solution contains 40 mg of docetaxel (anhydrous).
Jedan ml otopine docetaksela sadržava 40 mg bezvodnog docetaksela.
Each ml of liquid contains 1.1 g of glycerol phenylbutyrate.
Jedan ml tekućine sadrži 1,1 g glicerolfenilbutirata.
Each ml of liquid contains 1.1g of glycerol phenylbutyrate.
Jedan ml tekućine sadrži 1,1 g glicerolfenilbutirata.
Each ml of Norvir contains 80 mg ritonavir.
Svaki ml oralne otopine sadrži 80 mg ritonavira.
Each ml of ONIVYDE contains 0.144 mmol (3.31 mg) sodium.
Jedan ml lijeka ONIVYDE sadrži 0,144 mmol (3,31 mg) natrija.
Each ml of oral solution contains 10 mg lamivudine
Jedan ml otopine za oralnu otopinu sadrži 10 mg lamivudina.
Each ml of oral solution contains 100 mg deferiprone (25 g deferiprone in 250 ml and 50 g deferiprone in 500 ml).
Svaki ml oralne otopine sadrži 100 mg deferiprona (25 g deferiprona u 250 ml i 50 g deferiprona u 500 ml).
Each ml of oral solution contains 100 mg tipranavir.
Jedan ml oralne otopine sadrži 100 mg tipranavira.
Each ml of oral solution contains 20 mg of abacavir (as sulfate)
Jedan ml oralne otopine sadrži 20 mg abakavira (u obliku abakavirsulfata).
Each ml of oral solution contains 80 mg of ritonavir.
Svaki ml oralne otopine sadrži 80 mg ritonavira.
Each ml of oral suspension contains 1.2 mg methyl parahydroxybenzoate (E218), 0.3 mg propyl parahydroxybenzoate (E216) and 250 mg sorbitol (E420).
Jedan ml oralne suspenzije sadrži 1,2 mg metilparahidroksibenzoata (E218), 0,3 mg propilparahidroksibenzoata (E216) i 250 mg sorbitola (E420).
Each ml of oral suspension contains 10 mg of nevirapine (as hemihydrate)
Svaki ml oralne suspenzije sadrži 10 mg nevirapina (u obliku hemihidrata)
Each ml of oral suspension contains 175 mg sorbitol (E420).
Jedan ml oralne suspenzije sadrži 175 mg sorbitola (E420).
Each ml of oral suspension contains 250 mg sorbitol.
Jedan ml oralne suspenzije sadrži 250 mg sorbitola.
Each mL of oral suspension contains 40 mg of posaconazole.
Jedan ml oralne suspenzije sadrži 40 mg posakonazola.
Each mL of reconstituted solution contains 7 mg of sodium.
Svaki ml rekonstituirane otopine sadrži 7 mg natrija.
Each ml of reconstituted suspension contains oseltamivir phosphate equivalent to 12 mg of oseltamivir.
Jedan ml rekonstituirane suspenzije sadrži oseltamivirfosfat koji odgovara 12 mg oseltamivira.
Each ml of reconstituted vaccine contains:
Jedan ml rekonstituiranog cjepiva sadrži:
Each mL of solution contains 0.194 mmol (equivalent to 4.5 mg) of sodium.
Svaki ml otopine sadrži 0,194 mmol (što odgovara 4,5 mg) natrija.
Each ml of solution contains 0.8 mg of sildenafil (as citrate).
Jedan ml otopine sadrži 0,8 mg sildenafila u (obliku sildenafilcitrata).
Each ml of solution contains 1 mg elosulfase alfa*.
Svaki ml otopine sadrži 1 mg elosulfaze alfa*.
Each ml of solution contains 1 mg galsulfase.
Jedan ml otopine sadrži 1 mg galsulfaze.
Each ml of solution contains 1 mg galsulfase.
Svaki ml otopine sadrži 1 mg galsulfaze.
Each ml of solution contains 1 mg of temoporfin.
Jedan ml otopine sadrži 1 mg temoporfina.
Each ml of solution contains 1,000 micrograms fentanyl (as citrate)
Jedan ml otopine sadrži 1000 mikrograma fentanila (u obliku fentanilcitrata).
Each ml of solution contains 1,000 micrograms fentanyl (as citrate).
Jedan ml otopine sadrži 1000 mikrograma fentanila (u obliku fentanilcitrata).
Each ml of solution contains 1.3 GBq Samarium (153Sm) lexidronam pentasodium at the reference date (corresponding to 20 to 80 µg/ml of samarium per vial)
Svaki ml otopine sadrži 1,3 GBq samarijevog (153Sm) leksidronama, u obliku pentanatrijeve soli, na referentni datum (što odgovara 20 do 80 µg/ml samarija po bočici).
Each ml of solution contains 1.3 GBq Samarium (153Sm) lexidronam pentasodium at the reference date (corresponding to 20-80 µg/ml of samarium per vial).
Jedan ml otopine sadrži 1,3 GBq samarijevog(153Sm) leksidronama, u obliku pentanatrijeve soli, na referentni datum (što odgovara 20 do 80 µg/ml samarija po bočici).
Each ml of solution contains 10 mg lacosamide.
Jedan ml otopine za infuziju sadrži 10 mg lakozamida.
Each ml of solution contains 10 mg lipegfilgrastim.
Jedan ml otopine sadrži 10 mg lipegfilgrastima.
Each ml of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per ml
Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
Each ml of solution contains 100 mg of asfotase alfa*.
Jedan ml otopine sadrži 100 mg asfotaze alfa*.
Each mL of solution contains 100 units (U) of insulin degludec.
Jedan ml otopine sadrži 100 jedinica (U) degludek inzulina.
Each mL of solution contains 1100 kBq radium-223 dichloride, corresponding to 0.58 ng radium-223 at the reference date.
Svaki ml otopine sadrži 1100 kBq radij-223 diklorida, što odgovara 0,58 ng radija-223 na referentni datum.
Each ml of solution contains 150 mg lidocaine and 50 mg prilocaine.
Svaki ml otopine sadržava 150 mg lidokaina i 50 mg prilokaina.
Each mL of solution contains 1mg of olopatadine (as hydrochloride).
Svaki ml otopine sadrži 1 mg olopatadina (u obliku olopatadinklorida).
Each ml of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per ml
Jedan ml otopine sadrži 2000 IU epoetina alfa*, što odgovara 16,8 mikrograma po ml.
Each ml of solution contains 20 mg of caffeine citrate (equivalent to 10 mg of caffeine base).
Jedan ml otopine sadrži 20 mg kofeincitrata (što odgovara 10 mg kofeina u obliku baze).
Each mL of solution contains 200 units (U) of insulin degludec.
Jedan ml otopine sadrži 200 jedinica (U) degludek inzulina.
Each ml of solution contains 4,000 micrograms fentanyl (as citrate)
Jedan ml otopine sadrži 4000 mikrograma fentanila (u obliku fentanilcitrata).
Each ml of solution contains 4,000 micrograms fentanyl (as citrate).
Jedan ml otopine sadrži 4000 mikrograma fentanila (u obliku fentanilcitrata).
Each ml of solution contains 40 mg of asfotase alfa*.
Jedan ml otopine sadrži 40 mg asfotaze alfa*.
Each ml of solution contains 40 micrograms travoprost and 5 mg timolol (as timolol maleate).
Svaki ml otopine sadrži 40 mikrograma travoprosta i 5 mg timolola (u obliku timololmaleata).
Each ml of solution contains 400 micrograms glycopyrronium bromide equivalent to 320 micrograms glycopyrronium.
Jedan ml otopine sadrži 400 mikrograma glikopironijeva bromida, što odgovara 320 mikrograma glikopironija.
Each ml of solution contains 47 mg sorbitol (E420) (see section 4.4).
Jedan ml otopine sadrži 47 mg sorbitola (E420) (vidjeti dio 4.4).
Each ml of solution contains 5 mg methylthioninium chloride.
Svaki ml otopine sadrži 5 mg metiltioninijeva klorida.
Each ml of solution contains 5 mg of nelarabine.
Jedan ml otopine sadrži 5 mg nelarabina.
Each mL of solution contains 50 mg of sorbitol (E420) For the full list of excipients, see section 6.1.
Jedan ml otopine sadrži 50 mg sorbitola (E420) Za cjeloviti popis pomoćnih tvari, vidjeti dio 6.1.
Each ml of solution contains 50 mg sorbitol (E420).
Jedan ml otopine sadrži 50 mg sorbitola (E420).
Each ml of solution contains 50 micrograms of benzalkonium chloride.
Jedan ml otopine sadrži 50 mikrograma benzalkonijevog klorida.
Each ml of solution contains 50 micrograms of palonosetron (as hydrochloride).
Jedan ml otopine sadrži 50 mikrograma palonozetrona (u obliku palonozetronklorida).
Each ml of solution contains 50 micrograms palonosetron.
Jedan ml otopine sadrži 50 mikrograma palonosetrona.
Each mL of solution contains 500 mg of sodium oxybate.
Jedan mL otopine sadrži 500 mg natrijeva oksibata.
Each mL of solution contains 500 mg sodium oxybate
Jedan mL otopine sadrži 500 mg natrijeva oksibata
Each ml of solution contains 6.7 mg of somatropin (corresponding to 20 IU)
Jedan ml otopine sadrži 6,7 mg somatropina (što odgovara vrijednosti od 20 IU).
Each ml of solution contains 60 million units (MU) (equivalent to 600 micrograms [μg]) filgrastim*.
Jedan ml otopine sadrži 60 milijuna jedinica (MU) (što odgovara 600 mikrograma [μg]) filgrastima*.
Each ml of solution contains 60 million units (MU) (equivalent to 600 micrograms [μg]) of filgrastim.
Jedan ml otopine sadrži 60 milijuna jedinica (MU) (što odgovara 600 mikrograma [µg]) filgrastima.
Each ml of solution contains 96 million units (MU) (equivalent to 960 micrograms [μg]) filgrastim*.
Jedan ml otopine sadrži 96 milijuna jedinica (MU) (što odgovara 960 mikrograma [μg]) filgrastima*.
Each mL of solution contains a total of 100 units (U) insulin degludec/insulin aspart in the ratio 70/30.
Jedan ml otopine sadrži ukupno 100 jedinica (U) degludek inzulina/aspart inzulina u omjeru 70/30.
Each ml of solution contains fentanyl citrate equivalent to 1,000 micrograms fentanyl.
Jedan ml otopine sadrži fentanilcitrat što odgovara 1000 mikrograma fentanila.
Each ml of solution contains fentanyl citrate equivalent to 2,000 micrograms fentanyl.
Jedan ml otopine sadrži fentanilcitrat što odgovara 2000 mikrograma fentanila.
Each ml of solution contains fentanyl citrate equivalent to 500 micrograms fentanyl.
Jedan ml otopine sadrži fentanilcitrat što odgovara 500 mikrograma fentanila.
Each mL of solution contains flutemetamol (18F) 400 MBq at reference date and time.
Svaki mL otopine sadrži 400 MBq flutemetamola (18F) u referentnom datumu i vremenu.
Each mL of solution contains flutemetamol (18F) 400 MBq at reference date and time.
Svaki mL otopine sadrži flutemetamola (18F) 400 MBq u referentnom datumu i vremenu.
Each mL of solution contains flutemetamol (18F) 400 MBq at reference time.
Svaki mL otopine sadrži 400 MBq flutemetamola (18F) u referentnom vremenu.
Each ml of solution contains ioflupane (123I) 74 MBq at reference time (0.07 to 0.13 μg/ml of ioflupane).
Jedan ml otopine sadrži 74 MBq ioflupana (123I) u referentnom vremenu (0,07 do 0,13 μg/ml ioflupana).
Each mL of solution contains polyquaternium-1 (POLYQUAD) 10 microgram, propylene glycol 5 mg, polyoxyethylene hydrogenated castor oil 40 1 mg (see section 4.4).
Svaki ml otopine sadrži 10 mikrograma polikvaternija-1 (POLYQUAD), 5 mg propilenglikola, 1 mg polioksietilen hidrogeniranog ricinusovog ulja 40 (vidjeti dio 4.4)
Each ml of solution contains vortioxetine (D,L)-lactate equivalent to 20 mg vortioxetine.
Svaki ml otopine sadrži vortioksetin (D,L)-laktat u količini koja odgovara 20 mg vortioksetina (vortioxetinum).
Each ml of solution for infusion contains 0.75 mg of eptifibatide.
1 ml otopine sadržava 0,75 mg eptifibatida.
Each mL of solution for infusion contains 5 mg cetuximab.
Jedan ml otopine za infuziju sadrži 5 mg cetuksimaba.
Each ml of solution for infusion contains includes 2.99 mg sodium.
Jedan ml otopine za infuziju sadrži 2,99 mg natrija.
Each mL of solution for injection contains 1900 MBq of florbetapir (18F) at date and time of calibration (ToC).
Jedan ml otopine za injekciju sadrži 1900 MBq florbetapira (18F) na dan i sat kalibriranja (ToC).
Each mL of solution for injection contains 1900 MBq of florbetapir (18F) at the date and time of calibration (ToC).
Jedan ml otopine za injekciju sadrži 1900 MBq florbetapira (18F) na dan i sat kalibriranja (engl. time of calibration, ToC).
Each ml of solution for injection contains 2 mg of eptifibatide.
1 ml otopine sadržava 2 mg eptifibatida.
Each ml of solution for injection contains 2 mg of eptifibatide.
Jedan ml otopine za injekcije sadržava 2 mg eptifibatida.
Each mL of solution for injection contains 400 MBq of flutemetamol (18F) at reference date and time.
Svaki ml otopine za injekciju sadrži 400 MBq flutemetamola (18F) u referentnom datumu i vremenu.
Each mL of solution for injection contains 800 MBq of florbetapir (18F) at the date and time of calibration (ToC).
Jedan ml otopine za injekciju sadrži 800 MBq florbetapira (18F) na dan i sat kalibriranja (engl. time of calibration, ToC).
Each mL of solution for injection or infusion contains 60 million international units [MIU] (600 µg) of filgrastim.
Jedan ml otopine za injekciju ili infuziju sadrži 60 milijuna internacionalnih jedinica [MIU] ( 600 μg) filgrastima.
Each mL of solution for injection or infusion contains 60 million international units [MIU] (600 µg) of filgrastim.
Jedan ml otopine za injekciju ili infuziju sadrži 60 milijuna internacionalnih jedinica [MIU] (600 μg) filgrastima.
Each ml of solution for injection or infusion contains 60 million units [MU] (600 micrograms) of filgrastim*.
Jedan ml otopine za injekciju ili infuziju sadrži 60 milijuna jedinica [MU] (600 mikrograma) filgrastima*.
Each ml of solution for injection or infusion contains 96 million units [MU] (960 micrograms) of filgrastim*.
Jedan ml otopine za injekciju ili infuziju sadrži 96 milijuna jedinica [MU] (960 mikrograma) filgrastima*.
Each ml of solution for injection/infusion contains includes 3.8 mg sodium.
Jedan ml otopine za injekciju/infuziju sadrži 3,8 mg natrija.
Each ml of Stocrin oral solution contains 30 mg of the active substance efavirenz.
Jedan ml Stocrin oralne otopine sadrži 30 mg djelatne tvari efavirenza.
Each mL of suspension contains 0.03 mg of benzalkonium chloride.
Svaki ml suspenzije sadrži 0,03 mg benzalkonijeva klorida.
Each ml of suspension contains 0.05 mg benzalkonium chloride
Svaki ml suspenzije sadrži 0,05 mg benzalkonijeva klorida.
Each ml of suspension contains 0.05 mg of benzalkonium chloride.
Svaki ml suspenzije sadrži 0,05 mg benzalkonijeva klorida.
Each ml of suspension contains 0.54 g sucrose.
Jedan ml suspenzije sadrži 0,54 g saharoze.
Each ml of suspension contains 10 mg of brinzolamide
Svaki ml suspenzije sadrži 10 mg brinzolamida
Each ml of suspension contains 100 mg darunavir (as ethanolate).
Jedan ml suspenzije sadrži 100 mg darunavira (u obliku etanolata).
Each ml of suspension contains 12 mg oseltamivir.
Svaki ml suspenzije sadrži 12 mg oseltamivira
Each ml of suspension contains 6 mg oseltamivir.
Svaki ml suspenzije sadrži 6 mg oseltamivira.
Each ml of the diluted solution contains approximately 3.5 mg of sodium (sodium chloride 9 mg/ml (0.9%) solution for injection), 0.64 mg sodium (5% glucose solution for injection) or 3.2 mg sodium (Lactated Ringers solution for injection).
Jedan ml razrijeđene otopine sadrži približno 3,5 mg natrija (otopina natrijevog klorida za injekciju od 9 mg/ml (0,9%)), 0,64 mg natrija (5%-tna otopina glukoze za injekciju) ili 3,2 mg natrija (Ringerova otopina s laktatom za injekciju).
Each ml of the oral solution contains 5 mg lamivudine.
Jedan ml oralne otopine sadrži 5 mg lamivudina
Each ml of the oromucosal gel contains:
Svaki ml oromukoznog gela sadrži:
Each mL of the reconstituted solution contains 600 IU.
Svaki mililitar pripremljene otopine sadrži 600 IU.
Each mL of the reconstituted solution contains 600 IU. recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Svaki mililitar rekonstituirane otopine sadrži 600 IU. rekombinantan ljudski folikulo-stimulirajući hormon (r-hFSH), proizveden u stanicama jajnika kineskog hrčka (CHO) dobivenih tehnologijom rekombinantne DNK.
Each mL of the reconstituted solution contains 75 IU.
Svaki mililitar pripremljene otopine sadrži 75 IU.
Each mL of the reconstituted solution contains 75 IU. recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Svaki mililitar rekonstituirane otopine sadrži 75 IU. rekombinantan ljudski folikulo-stimulirajući hormon (r-hFSH), proizveden u stanicama jajnika kineskog hrčka (CHO) dobivenih tehnologijom rekombinantne DNK.
Each ml of the solution contains 0.04 mg zoledronic acid (as monohydrate).
Jedan ml otopine sadrži 0,04 mg zoledronatne kiseline (u obliku hidrata).
Each ml of the solution contains 0.05 mg zoledronic acid (as monohydrate).
Jedan ml otopine sadrži 0,05 mg zoledronatne kiseline (u obliku hidrata).
Each ml of the solution contains 0.05 mg zoledronic acid (as monohydrate).
Svaki ml otopine sadrži 0,05 mg zoledronatne kiseline (u obliku hidrata).
Each ml of the solution contains 0.05 mg zoledronic acid (as monohydrate).
Svaki ml otopine sadrži 0,05 zoledronatne kiseline (u obliku hidrata).
Each ml of the solution contains 0.05 mg zoledronic acid anhydrous (as monohydrate).
Jedan ml otopine sadrži 0,05 mg zoledronatne kiseline bezvodne (u obliku hidrata).
Each ml of the solution contains 5 mg ibuprofen.
Svaki ml otopine sadrži 5 mg ibuprofena.
Each mL of the solution contains 600 IU (equivalent to 44 micrograms) follitropin alfa*.
Jedan ml otopine sadrži 600 IU (što odgovara 44 mikrograma) folitropina alfa*.
Each mL of the solution contains 600 IU (equivalent to 44 micrograms) follitropin alfa.
Svaki ml otopine sadrži 600 IU (što odgovara 44 mikrograma) folitropina alfa.
Each ml of the solution contains 600 IU (equivalent to 44 micrograms) of follitropin alfa*.
Svaki ml otopine sadrži 600 IU (što odgovara 44 mikrograma) folitropina alfa*.
Each ml of the solution contains 600 IU equivalent to 44 micrograms.
Svaki ml otopine sadrži 600 IU što odgovara 44 mikrograma.
Each mL of the solution contains 600 IU of follitropin alfa*, (equivalent to 44 micrograms).
Svaki mililitar otopine sadrži 600 IU folitropina alfa*, (odgovara 44 mikrograma).
Each mL of the solution for infusion contains 5 mg cetuximab.
Jedan ml otopine za infuziju sadržava 5 mg cetuksimaba.
Each ml of Vimpat syrup contains 187 mg sorbitol (E420), 2.60 mg sodium methyl parahydroxybenzoate (E219), 0.032 mg aspartame (E951), and 1.42 mg sodium.
Jedan ml Vimpat sirupa sadrži 187 mg sorbitola (E420), 2,60 mg natrijeva metilparahidroksibenzoata (E219), 0,032 mg aspartama (E951) i 1,42 mg natrija.
Each ml oral solution contains 1 mg of aripiprazole.
Jedan ml sadrži 1 mg aripiprazola.
Each ml reconstituted suspension contains 0.08 mg mifamurtide.
Svaki ml rekonstituirane suspenzije sadrži 0,08 mg mifamurtida.
Each modified-release tablet contains 96.9 mg sucrose (includes 0.7 mg sucrose as sucrose monopalmitate), 59.8 mg lactose (as monohydrate) and 0.2 mg maltitol liquid.
Jedna tableta s prilagođenim oslobađanjem sadrži 96,9 mg saharoze (uključuje 0,7 saharoze u obliku saharoza palmitata), 59,8 mg laktoze (u obliku hidrata) i 0,2 mg tekućeg maltitola.
Each modified-release tablet contains hydrocortisone 20 mg.
Jedna tableta s prilagođenim oslobađanjem sadrži 20 mg hidrokortizona.
Each modified-release tablet contains hydrocortisone 5 mg.
Jedna tableta s prilagođenim oslobađanjem sadrži 5 mg hidrokortizona.
Each Moventig 12.5 mg film-coated tablet (tablet) contains 12.5 mg naloxegol as naloxegol oxalate.
Jedna Moventig 12,5 mg filmom obložena tableta (tableta) sadrži 12,5 mg naloksegola u obliku naloksegoloksalata.
Each Moventig 25 mg film-coated tablet (tablet) contains 25 mg naloxegol as naloxegol oxalate.
Jedna Moventig 25 mg filmom obložena tableta (tableta) sadrži 25 mg naloksegola u obliku naloksegoloksalata.
Each multidose vial contains 1.0 to 10 mL of solution, corresponding to 300 to 3000 MBq at the date and time of calibration (ToC).
Jedna višedozna bočica sadrži 1,0 do 10 ml otopine, što odgovara 300 do 3000 MBq na dan i sat kalibriranja (ToC).
Each multidose vial contains 1.0 to 10 mL of solution, corresponding to 300 to 3000 MBq of florbetaben (18F) at the date and time of calibration.
Jedna višedozna bočica sadrži 1,0 do 10 ml otopine, što odgovara 300 do 3000 MBq florbetabena (18F) na dan i sat kalibriranja.
Each new injection should be given at least 3 cm from the last injection site.
Novo mjesto ubrizgavanja treba biti udaljeno barem 3 cm od mjesta na kojem je injicirana prethodna injekcija.
Each new injection should be given on a separate site from the last injection site.
Svaki put odaberite drugo mjesto injiciranja.
Each new injection should be given on a separate site from the last injection site.
Svaku novu injekciju treba dati na različito mjesto od zadnjeg mjesta injiciranja.
Each NexoBrid vial, gel, or reconstituted gel should be used for a single patient only.
Jedna bočica, gel i pripremljeni gel NexoBrid smiju se primijeniti u samo jednog bolesnika.
Each NULOJIX vial provides 250 mg of belatacept.
Jedna bočica lijeka NULOJIX sadrži 250 mg belatacepta.
Each of the components contributed to the reduction in the primary composite endpoint (CV death 17% RRR, MI 16% RRR, and stroke 25% RRR).
Svaka od komponenti doprinijela je smanjenju primarnog kompozitnog ishoda (KV smrt 17% RRR, IM 16% RRR i moždani udar 25% RRR).
Each of the ten capsules is put into the inhaler one at a time.
Svaku od deset kapsula stavljajte u inhalator jednu po jednu.
Each of the ten serious cases involving bradycardia occurred in the context of infusion- associated reactions.
Svaki od deset ozbiljnih slučajeva koji su uključivali bradikardiju pojavili su se kod reakcija povezanih s infuzijom.